comparemela.com

Latest Breaking News On - Catalio capital management - Page 3 : comparemela.com

Dianthus Therapeutics Announces $230 Million Private Placement

NEW YORK and WALTHAM, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) Dianthus Therapeutics, Inc. (“Dianthus” or the “Company”) (NASDAQ: DNTH), a clini.

New yorkUnited statesRaymond jamesTellus bioventuresExchange commissionDianthus therapeutics incBain capital life sciencesGreat point partnersCompany quarterly report on formAvidity partnersVenrock healthcare capital partnersOctagon capitalJanus henderson investorsVestal point capitalLogos capitalCatalio capital management

Lassen Therapeutics Lands $85M Series B - San Diego Business Journal

Lassen Therapeutics Lands $85M Series B - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesBrian liuMaria fardisLongwood fundFrazier life sciencesLassen therapeuticsLongitude capitalCatalio capital managementAlta partnersHorizon therapeuticsLongitude capital managing director brian liu

Lassen Therapeutics Lands $85M Series B - San Diego Business Journal

Lassen Therapeutics Lands $85M Series B - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesBrian liuMaria fardisFrazier life sciencesLongwood fundLassen therapeuticsLongitude capitalCatalio capital managementAlta partnersLongitude capital managing director brian liu

Gene editing startup Metagenomi files for an IPO

BioPharma

United statesArrivent biopharmaNovo holdingsUniversity of californiaNovo nordiskIonis pharmaceuticalsDive briefBiopharma diveCatalio capital management

HongShan-backed OnCusp Therapeutics snags $100m Series A

OnCusp Therapeutics has raised $100 million in a Series A funding round co-led by Novo Holdings, OrbiMed, and F-Prime Capital.

New yorkUnited statesChong xuEric slosbergDaiichi sankyoDiyong xuBlackbird bioventuresSandy fuKaren hongMarshall waceNovo holdingsCstone pharmaceuticalsOncusp therapeuticsF prime capitalBiotrack capitalSofinnova investments

vimarsana © 2020. All Rights Reserved.